Topic: Gene Splicing

The hosts debate whether the new mRNA vaccines should be classified as "gene modification" or "gene splicing." While they admit they are not experts, they argue that the process of injecting genetic instructions to produce proteins represents a fundamental shift in medical technology.

The hosts revisit a JPMorgan Chase report highlighting the pharmaceutical industry's shift toward vaccines as a primary profit center. They discuss the legal indemnification of vaccine makers and the experimental nature of RNA vaccines. Curry notes that these new treatments involve gene splicing and have never been proven to work in a traditional sense.